GLP-1s show a clear kidney protective signal in patients with T2D associated CKD Novo Nordisks FLOW trial provided the field with the first dedicated, convincing evidence that semaglutide, known under the brand name Ozempic, can slow renal decline, with its 24% placebo-adjusted reduction in a composite kidney endpoint across 3,533 adults with T2D and CKD
Rather than asking you to override your hunger signals through determination, these medications work with the same biological pathways that your body already uses to regulate appetite
The presentations underscore Ascletis' commitment to addressing the global obesity epidemic through innovative, highly targeted oral therapeutics with favorable safety profiles
Glutathione is a tripeptide made from three amino acids: Glutamate (glutamic acid) Cysteine (the rate-limiting building block) Glycine Together, these form a molecule your cells use in many essential processes, including: Neutralizing reactive oxygen species (free radicals) Supporting metabolic detoxification through enzyme systems (e.g., glutathione S-transferases) Regenerating other antioxidants like vitamin C and E Protecting mitochondria and other cellular structures from oxidative damage Supporting normal immune and liver function Your body produces glutathione continuously but it needs the right raw materials and metabolic support to keep up
